A small molecule modulator of the tumor suppressor miRNA-34a inhibits the growth of hepatocellular carcinoma

Small molecules that restore the expression of growth inhibitory microRNAs downregulated in tumors may have potential as anticancer agents. miR-34a functions as a tumor suppressor and is downregulated or silenced commonly in a variety of human cancers including hepatocellular carcinoma (HCC). In this study, we used an HCC cell-based miR-34a luciferase reporter system to screen for miR-34a modulators that could exert anticancer activity. One compound identified as a lead candidate, termed Rubone, was identified through its ability to specifically upregulate miR-34a in HCC cells. Rubone activated miR-34a expression in HCC cells with wild type or mutated p53 but not in cells with p53 deletions. Notably, Rubone lacked growth inhibitory effects on non-tumorigenic human hepatocytes. In a mouse xenograft model of HCC, Rubone dramatically inhibited tumor growth, exhibiting stronger anti-HCC activity than sorafenib both in vitro and in vivo. Mechanistic investigations showed that Rubone decreased expression of Cyclin D1, Bcl-2 and other miR-34a target genes and that it enhanced the occupancy of p53 on the miR-34a promoter. Taken together, our results offer a preclinical proof of concept for Rubone as a lead candidate for further investigation as a new class of HCC therapeutic based on restoration of miR-34a tumor suppressor function.